Australian biotech market today 02.04.09
Thursday, 02 April, 2009
Healthcare is up 2 per cent on a good day’s trading on the stock exchange at 1.30pm.
Pharmaxis (ASX:PXS) is up 11c, or 6.4 per cent, on yesterday’s news it had reached a critical milestone in its Phase III trail of Bronchitol in cystic fibrosis patients.
Mesoblast (ASX:MSB) is up 2.5 per cent on recent news it had raised over $10 million from private and sophisticated investors.
Cardiac catheter manufacturer CathRx (ASX:CXD) is up almost 13 per cent, while proteomics company Fluorotechnics (ASX:FLS) is down almost 20 per cent on very low volumes.
Pathology company Sonic Healthcare (ASX:SHL) is up 42c to $11.49.
Avita Medical (ASX:AVH) is up slightly on improved sales of its respiratory products Breath-A-Tech and Funhaler spacers.
Biota (ASX:BTA) is up 3c to 68c while CSL (ASX:CSL) is up almost 60c to0 $32.70.
Novogen (ASX:NRT) is up a touch, as is Phosphagenics (ASX:POH).
Quitting smoking increases life expectancy even for seniors
Although the benefits of quitting smoking diminish with age, there are still substantial gains...
Stem cell transplants treat blindness in mini pigs
Scientists have successfully transplanted retinas made from stem cells into blind mini pigs,...
Sugary drinks raise cardiovascular disease risk, but occasional sweets don't
Although higher sugar intake raises your risk of certain cardiovascular diseases, consuming sweet...
